Literature DB >> 2647276

Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma.

K Sugiyama1, Y Yonemura, I Miyazaki.   

Abstract

Immunohistochemical study for epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) was performed on 222 specimens of gastric carcinoma. The authors placed each carcinoma into one of the following three groups: group 1, neither EGF nor EGFR was stained (123 cases); group 2, either EGF or EGFR was stained (64 cases); and group 3, both EGF and EGFR were stained (35 cases). Compared with the carcinomas in groups 1 and 2, those in group 3 had significantly higher rates of infiltrative gross type, microscopically infiltrative type, poorly differentiated type, scirrhous type, and deep invading type. These results suggest that carcinomas in group 3 may have more proliferative and invasive activity and thus may have an autocrine mechanism, that is, the ability of cancer cells to produce and respond to their own growth factor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647276     DOI: 10.1002/1097-0142(19890415)63:8<1557::aid-cncr2820630818>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hayato Nakagawa; Kei Sakamoto; Yohko Hikiba; Hiroto Kinoshita; Wachiko Nakata; Ryota Takahashi; Keisuke Tateishi; Motohisa Tada; Masao Akanuma; Haruhiko Yoshida; Kohsuke Takeda; Hidenori Ichijo; Masao Omata; Shin Maeda; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer.

Authors:  M Onda; A Tokunaga; K Nishi; T Yoshiyuki; Y Shimizu; T Kiyama; T Mizutani; N Matsukura; N Tanaka; K Yamashita
Journal:  Jpn J Surg       Date:  1990-05

4.  Expression of human epidermal growth factor and its receptor in esophageal cancer.

Authors:  H Mukaida; T Yamamoto; T Hirai; M Toi; T Nakamura; T Wada; Y Yamashita; K Kawano; M Niimoto
Journal:  Jpn J Surg       Date:  1990-05

5.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.

Authors:  M Ramael; K Segers; C Buysse; J Van den Bossche; E Van Marck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Epidermal growth factor receptor expression in squamous cell lung carcinomas: an immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded material.

Authors:  V Gorgoulis; A Giatromanolaki; A Karameris; C Tsatsanis; D Aninos; B Ozanne; M Veslemes; J Jordanoglou; R Trigidou; H Papastamatiou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia.

Authors:  S Tanaka; K Imanishi; M Yoshihara; K Haruma; K Sumii; G Kajiyama; S Akamatsu
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

9.  Stimulatory effect of EGF and inhibitory effect of sialoadenectomy on growth of an EGF receptor-hyperproducing human gastric cancer xenograft in nude mice.

Authors:  T Okuda; M Onda; A Tokunaga; Y Sugisaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

10.  Superficial spreading type of early gastric cancer.

Authors:  K Kitamura; T Yamaguchi; K Okamoto; T Nishida; T Takahashi
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.